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A Corrigendum on
An Overview of MicroRNAs as Biomarkers of ALS
by Joilin, G., Leigh, P. N., Newbury, S. F., and Hafezparast, M. (2019). Front. Neurol. 10:186.
doi: 10.3389/fneur.2019.00186
In the original article, there was a mistake in Table 1 as published. Some of the miRNAs listed
in the table were incorrectly placed in the wrong column and/or row. The corrected Table 1
appears below.
The authors apologize for this error and state that this does not change the scientific conclusions
of the article in any way. The original article has been updated.
Copyright © 2019 Joilin, Leigh, Newbury and Hafezparast. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance












































TABLE 1 | Circulating miRNA-based biomarkers found to be differentially expressed in biofluids.
Authors ALS
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Sporadic 72 MIR338-3p – Age-matched
healthy controls


























































































































































































TABLE 1 | Continued
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Sporadic 72 MIR338-3p – Age-matched
healthy controls




































































































































TABLE 1 | Continued
Authors ALS
type






























































Those miRNA underlined show consistent directional changes between control and ALS cases while those in bold show contrasting directional changes between control and ALS cases.
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